Press Releases

 
Adamas Reports Inducement Grant to New Chief Financial Officer
Jul 10, 2017


Adamas Appoints New Chief Financial Officer
Jun 28, 2017


Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology
Jun 12, 2017


Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study Showing Tolerability and Durability out to 88 Weeks
Jun 8, 2017


Adamas to Present at Two Upcoming Investor Conferences
Jun 1, 2017


Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy
May 22, 2017


Adamas Signs $100 Million Royalty-Backed Note Agreement with HealthCare Royalty Partners
May 11, 2017


Adamas Reports Recent Achievements and First Quarter 2017 Financial Results
May 9, 2017


Adamas Reports Inducement Grant to New Chief Operating Officer
May 5, 2017


Adamas to Announce First Quarter 2017 Financial Results and Host Conference Call on May 9, 2017
May 2, 2017


Page:
1
NextLast